
Biogen has announced that its investigational gene therapy study for the potential treatment of choroideremia did not meet its primary …

A UK Phase I trial of a gene therapy designed to restore sight in patients suffering from an inherited form …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

